HeartBeam Statistics
Total Valuation
HeartBeam has a market cap or net worth of $28.34 million. The enterprise value is $19.62 million.
| Market Cap | 28.34M |
| Enterprise Value | 19.62M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HeartBeam has 56.35 million shares outstanding. The number of shares has increased by 39.05% in one year.
| Current Share Class | 56.35M |
| Shares Outstanding | 56.35M |
| Shares Change (YoY) | +39.05% |
| Shares Change (QoQ) | +30.02% |
| Owned by Insiders (%) | 9.01% |
| Owned by Institutions (%) | 16.33% |
| Float | 47.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 17.11 |
| PB Ratio | 3.47 |
| P/TBV Ratio | 3.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.66
| Current Ratio | 3.66 |
| Quick Ratio | 3.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -328.44% and return on invested capital (ROIC) is -206.42%.
| Return on Equity (ROE) | -328.44% |
| Return on Assets (ROA) | -153.52% |
| Return on Invested Capital (ROIC) | -206.42% |
| Return on Capital Employed (ROCE) | -249.59% |
| Weighted Average Cost of Capital (WACC) | -0.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.27M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.27% in the last 52 weeks. The beta is -0.79, so HeartBeam's price volatility has been lower than the market average.
| Beta (5Y) | -0.79 |
| 52-Week Price Change | -54.27% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 43.59 |
| Average Volume (20 Days) | 455,044 |
Short Selling Information
The latest short interest is 1.84 million, so 3.26% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short Previous Month | 2.54M |
| Short % of Shares Out | 3.26% |
| Short % of Float | 3.85% |
| Short Ratio (days to cover) | 1.84 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.41M |
| Pretax Income | -20.30M |
| Net Income | -20.30M |
| EBITDA | -20.30M |
| EBIT | -20.41M |
| Earnings Per Share (EPS) | -$0.50 |
Balance Sheet
The company has $8.72 million in cash and no debt, with a net cash position of $8.72 million or $0.15 per share.
| Cash & Cash Equivalents | 8.72M |
| Total Debt | n/a |
| Net Cash | 8.72M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 8.18M |
| Book Value Per Share | 0.15 |
| Working Capital | 6.54M |
Cash Flow
In the last 12 months, operating cash flow was -$13.02 million and capital expenditures -$993,000, giving a free cash flow of -$14.01 million.
| Operating Cash Flow | -13.02M |
| Capital Expenditures | -993,000 |
| Depreciation & Amortization | 106,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -14.01M |
| FCF Per Share | -$0.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HeartBeam does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.05% |
| Shareholder Yield | -39.05% |
| Earnings Yield | -71.61% |
| FCF Yield | -49.43% |
Analyst Forecast
The average price target for HeartBeam is $3.38, which is 571.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.38 |
| Price Target Difference | 571.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |